Bill Commons

IN HB 1399

died on adjournment

Ephedrine and pseudoephedrine products.

Indiana · 2026 Regular Session (2nd Regular Session, 124th General Assembly) · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did IN HB 1399 pass?

No. IN HB 1399 died when the 2026 Regular Session (2nd Regular Session, 124th General Assembly) adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-08): Authored by Representative Isa

What is IN HB 1399 about?

Requires the state police department (department) to oversee an electronic logging system (system) to: (1) record and monitor real time purchases of products containing ephedrine and pseudoephedrine; (2) monitor ephedrine and pseudoephedrine purchases to prevent or investigate the illegal purchase of ephedrine or pseudoephedrine; and (3) block illegal purchases of ephedrine and pseduoephedrine. Requires the department to contract with a third party vendor to operate the system. Requires each manufacturer of products that contain ephedrine and pseudoephedrine to demonstrate to the department that they have a valid contract with the vendor to provide electronic tracking of purchases in Indiana. Replaces "NPLEx system" references with "electronic logging system". Removes current restrictions on the sale of ephedrine and pseudoephedrine products to individuals who do not have a relationship on record with a pharmacy or have not completed a consultation with a pharmacy to determine if there is a legitimate medical or pharmaceutical need for the products.

Who sponsors IN HB 1399?

Tony Isa is the primary sponsor of IN HB 1399, joined by 2 cosponsors.

Description

Requires the state police department (department) to oversee an electronic logging system (system) to: (1) record and monitor real time purchases of products containing ephedrine and pseudoephedrine; (2) monitor ephedrine and pseudoephedrine purchases to prevent or investigate the illegal purchase of ephedrine or pseudoephedrine; and (3) block illegal purchases of ephedrine and pseduoephedrine. Requires the department to contract with a third party vendor to operate the system. Requires each manufacturer of products that contain ephedrine and pseudoephedrine to demonstrate to the department that they have a valid contract with the vendor to provide electronic tracking of purchases in Indiana. Replaces "NPLEx system" references with "electronic logging system". Removes current restrictions on the sale of ephedrine and pseudoephedrine products to individuals who do not have a relationship on record with a pharmacy or have not completed a consultation with a pharmacy to determine if there is a legitimate medical or pharmaceutical need for the products.

Introduced
—
Latest action
2026-01-08 — Authored by Representative Isa
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Tony Isaauthor
  • Kyle Millercoauthor
  • Doug Millercoauthor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-01-08

    Authored by Representative Isa

  2. 2026-01-08

    First reading: referred to Committee on Veterans Affairs and Public Safety

    reading-1,referral-committee

  3. 2026-01-08

    Coauthored by Representatives Miller D, Miller K

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:09.317128Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=IN&identifier=HB 1399. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.